Efficacy can be Improved by Engineered Anti-Toxin Antibodies

by Kathy Jones on  January 12, 2014 at 6:11 PM Research News
RSS Email Print This Page Comment
Font : A-A+

While the role of antibodies is quite clear in the sphere of immunology, researchers are still working on explaining the various mechanisms of action involved here.
 Efficacy can be Improved by Engineered Anti-Toxin Antibodies
Efficacy can be Improved by Engineered Anti-Toxin Antibodies

The effectiveness of toxin-neutralizing antibodies is considered to be mediated through the interaction of the variable region of the antibody and the toxin; however, recent studies suggest that the constant region (Fc) of antibodies also influence efficacy.In this issue of the Journal of Clinical Investigation, Jeffrey Ravetch and colleagues at The Rockefeller University demonstrate that engineering the Fc domain of anti-toxin antibodies increases toxin neutralization activity through enhancing the interaction between toxin-targeting antibodies and the Fc receptor on immune cells. The authors found that mice expressing humanized FcR were better protected from anthrax toxin when given engineered anti-anthrax toxin antibodies. This study suggests that engineering the Fc domains of antibodies can be used as a strategy to enhance antibody efficacy.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive